Braveheart Bio Targets $1.2 Billion Valuation in IPO
The heart-disease drug developer is seeking up to $318.8 million for clinical trials and research.
Archive
The heart-disease drug developer is seeking up to $318.8 million for clinical trials and research.
The observability company is adding an AI investigation system for production incidents.
The executive-search firm is adding an AI-focused recruiting team with startup customers.
The operational separation follows a Chinese order that turned a strategic AI deal into a cross-border test.
The ChatGPT maker joined Anthropic in a high-stakes race to bring frontier AI companies to public markets.
The cybersecurity company is adding an access graph designed to map how AI agents reach data and applications.
The applied engineering firm will become the operating core of a new enterprise AI implementation company.
The AI chipmaker nearly doubled its offering price as investors sought another route into compute infrastructure.
The customer-service agent company is adding a French team that connects AI with business processes.
The purchase brings a large catalog of video effects, templates and editing tools inside Apple.